VRNS INVESTOR NOTICE: Varonis Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

VRNS INVESTOR NOTICE: Varonis Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces GlobeNewswire January 29, 2026 SAN DIEGO, Jan. 28, 2026 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Varonis Systems, Inc. […]

Citi Enriches Private Market Offerings for Citigold Private Clients in Collaboration with Blackstone, Blue Owl and KKR

Citigold Private Clients will gain access to alternative asset classes including private equity and private infrastructure Citi Singapore and Citi Hong Kong have announced strategic partnerships with leading global private market firms Blackstone, Blue Owl and KKR, to launch evergreen funds for high net-worth clients who are seeking enhanced wealth solutions and greater portfolio diversification.

Bybit Leads Global XAUT Spot Trading with ~16% Market Share as Tokenized Gold Rallies to New Highs

Bybit, the world’s second-largest cryptocurrency exchange by trading volume, announced that it has become the No.1 centralized exchange for spot trading of Tether Gold (XAUT), commanding approximately 15.75% of total XAUT trading volume among centralized venues, according to CoinGecko data. The surge in XAUT activity coincides with the token hitting new all-time highs around $5,500,

Coupang Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Coupang, Inc. – CPNG

(NYSE:CPNG), NEW ORLEANS, Jan. 28, 2026 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against Coupang, Inc. (NYSE: CPNG), if they purchased or otherwise acquired the Company's securities between May 7, 2025 and December

Coupang Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Coupang, Inc. – CPNG

Coupang Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Coupang, Inc. – CPNG GlobeNewswire January 29, 2026 NEW ORLEANS, Jan. 28, 2026 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 17, 2026 to file lead

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Coupang, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – CPNG

New York, New York–(Newsfile Corp. – January 28, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Coupang, Inc. (NYSE: CPNG) between August 6, 2025 and December 16, 2025, both dates inclusive (the “Class Period”), of the important February 17, 2026 lead plaintiff deadline in the securities class

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Klarna Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KLAR

New York, New York–(Newsfile Corp. – January 28, 2026) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Klarna Group plc (NYSE: KLAR) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Klarna’s September 2025 initial public offering (the “IPO”),

WuXi Biologics and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Development and Manufacturing of Innovative Bispecific Antibody

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), and Sinorda Biomedicine today jointly announced a strategic collaboration for the development and manufacturing of SND006, a novel bispecific antibody, for the potential treatment of inflammatory bowel disease (IBD) and other autoimmune diseases. Under the agreement, Sinorda Biomedicine will leverage WuXi Biologics’

American Riviera Bancorp Announces Results for the Fourth Quarter of 2025

SANTA BARBARA, CA / ACCESS Newswire / January 28, 2026 / American Riviera Bancorp ("Company") (OTCQX:ARBV), holding company of American Riviera Bank ("Bank"), announced today unaudited net income of $12.4 million ($2.18 per share) for the year ended December 31, 2025, compared to $8.7 million ($1.50 per share) earned in the same reporting period in

NuRAN Provides Clarification and Corrections Regarding Restructuring Transaction Disclosure

QUEBEC, QC / ACCESS Newswire / January 28, 2026 / NuRAN Wireless Inc. ("NuRAN" or the "Company") (CSE:NUR)(OTC PINK:NRRWF)(FSE:1RN), announces, further to its prior press release of December 23, 2025, that its acquisition of Advance Factoring Inc. (the "Factor") has resulted in a restructuring transaction within the meaning of National Instrument 51-102 –Continuous Disclosure Obligations

Scroll to Top